Figures in parentheses refer to results during the corresponding period of the previous yearThe Group's sales amounted to 64.8 (61.2) MSEK for the third quarter of the year.The Group's net result tota ...
Completed pre-BLA meeting with FDA with full alignment on content of BLA, including CMC module, and path for fourth quarter 2024 rolling BLA submission for PRGN-2012† ...